CSS
COLL icon

Cubist Systematic Strategies’s Collegium Pharmaceutical COLL Stock Holding History

Cubist Systematic Strategies’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-92,992
Closed -$3.61M – 3154
2024
Q1 		$3.61M Buy
92,992
+20,663
+29% +$723K 0.02% 1195
2023
Q4 		$2.23M Sell
72,329
-5,826
-7% -$146K 0.01% 1429
2023
Q3 		$1.75M Buy
+78,155
New +$1.78M 0.01% 1464
2023
Q2 		– Sell
-196,096
Closed -$4.7M – 3619
2023
Q1 		$4.7M Buy
+196,096
New +$5.2M 0.03% 983
2022
Q4 		– Sell
-65,578
Closed -$1.05M – 4291
2022
Q3 		$1.05M Buy
+65,578
New +$1.16M 0.01% 2582
2022
Q2 		– Sell
-74,897
Closed -$1.52M – 4382
2022
Q1 		$1.52M Buy
74,897
+45,470
+155% +$859K 0.01% 1706
2021
Q4 		$550K Sell
29,427
-11,678
-28% -$228K 0.01% 2374
2021
Q3 		$811K Sell
41,105
-7,620
-16% -$165K 0.01% 1686
2021
Q2 		$1.15M Sell
48,725
-6,796
-12% -$157K 0.01% 1462
2021
Q1 		$1.32M Buy
55,521
+33,222
+149% +$789K 0.02% 1344
2020
Q4 		$447K Sell
22,299
-10,295
-32% -$201K 0.01% 1831
2020
Q3 		$679K Buy
32,594
+742
+2% +$13.4K 0.01% 1562
2020
Q2 		$557K Sell
31,852
-37,269
-54% -$730K 0.01% 1533
2020
Q1 		$1.13M Buy
69,121
+37,884
+121% +$782K 0.03% 754
2019
Q4 		$643K Buy
+31,237
New +$521K 0.01% 1401
2019
Q2 		– Sell
-33,248
Closed -$503K – 2468
2019
Q1 		$503K Buy
+33,248
New +$532K 0.02% 1196
2018
Q4 		– Sell
-10,309
Closed -$152K – 2089
2018
Q3 		$152K Buy
10,309
+1,383
+15% +$24.5K 0.01% 1493
2018
Q2 		$213K Buy
+8,926
New +$219K 0.01% 1311

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Cubist Systematic Strategies's COLL Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 92,992 shares — an estimated $3.61M sold.

Cubist Systematic Strategies first reported a position in COLL in Q2 2018 and held it in 18 quarters. The position peaked at $4.7M in Q1 2023. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 92,992 Collegium Pharmaceutical shares in Q2 2024, an estimated $3.61M.
  • Cubist Systematic Strategies first reported a position in Collegium Pharmaceutical in Q2 2018 and held it in 18 quarters.
  • Cubist Systematic Strategies's Collegium Pharmaceutical position peaked at $4.7M in Q1 2023.
  • 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.